TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort-Reference-Cited by-同舟云学术

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort

Published:2007-01-22 Issue:31 Volume:26 Page:4596-4599
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Demichelis F,Fall K,Perner S,Andrén O,Schmidt F,Setlur S R,Hoshida Y,Mosquera J-M,Pawitan Y,Lee C,Adami H-O,Mucci L A,Kantoff P W,Andersson S-O,Chinnaiyan A M,Johansson J-E,Rubin M A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1210237.pdf

Reference21 articles.

1. Andren O, Fall K, Franzen L, Andersson SO, Johansson JE, Rubin MA . (2006). How well does the Gleason score predict prostate cancer death? A 20-year followup of a population based cohort in Sweden. J Urol 175: 1337–1340.

2. Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson SO, Bratell S et al. (2005). Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352: 1977–1984.

3. Carver BS, Bianco Jr FJ, Scardino PT, Eastham JA . (2006). Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer. J Urol 176: 564–568.

4. Holmberg L, Bill-Axelson A, Helgesen F, Salo JO, Folmerz P, Haggman M et al. (2002). A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 347: 781–789.

5. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C et al. (2006). Cancer statistics, 2006. CA Cancer J Clin 56: 106–130.

Cited by 529 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostatic adenocarcinoma: molecular underpinnings and treatment-related options;Urologic Oncology: Seminars and Original Investigations;2024-07

2. Diverse landscape of genetically engineered mouse models: Genomic and molecular insights into prostate cancer;Cancer Letters;2024-07

3. The Benefit of Combining Docetaxel with Androgen Deprivation Therapy in Localized and Metastatic Hormone-sensitive Prostate Cancer is Predicted by ERG Expression: An Analysis of Two GETUG Phase 3 Trials;European Urology Oncology;2024-07

4. Prostate cancer biomarkers: from early diagnosis to precision treatment;Clinical and Translational Oncology;2024-05-14

5. The yin and yang of chromosomal instability in prostate cancer;Nature Reviews Urology;2024-02-02